• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Dec 1;29(1).
doi: 10.3201/eid2901.221293. Online ahead of print.
Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022

Sarah Foulkes, Edward J M Monk, Dominic Sparkes, Nipunadi Hettiarachchi, Iain D Milligan, Katie Munro, Andrew Taylor-Kerr, Naomi Platt, Anna Howells, Jerry Ye Aung Kyaw, Enemona Adaji, Eileen Gallagher, Jameel Khawam, Edgar Wellington, Lesley Price, David Crossman, Chris Norman, Elen de Lacy, Lisa Cromey, Diane Corrigan, Angie Lackenby, Paola Barbero, Busayo Elegunde, Maria Zambon, Meera A Chand, Colin S Brown, Jasmin Islam, Ana Atti, Susan Hopkins, Victoria J Hall, Michelle J Cole, SIREN Study Group3

Abstract

Since June 2020, the SARS-CoV-2 Immunity and Reinfection Evaluation (SIREN) study has conducted routine PCR testing in UK healthcare workers and sequenced PCR-positive samples. SIREN detected increases in infections and reinfections during Omicron subvariant waves contemporaneous with national surveillance. SIREN's sentinel surveillance methods can be used for variant surveillance.

Keywords: BA.1; BA.2; BA.4; BA.5; COVID-19; Omicron variant; SARS; SARS-CoV-2; SIREN study; United Kingdom; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom